Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Clift, D. Studer, P. Wick, T. Geiser, P. Gehr, R. Schins, B. Rothen-Rutishauser (Bern, St. Gallen, Switzerland; Duesseldorf, Germany). An evaluation of the potential for inhaled xenobiotics to develop cancer in the lung using a 3D in vitro model of the human epithelial airway-wall. Eur Respir J 2011; 38: Suppl. 55, 2783

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 PBI-4050 reduces expression of fibrosis biomarkers in the BioMAP SAEMyoF primary human small airway epithelial cells and lung myofibroblasts system Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 A 3D tissue-engineered airway model for the assessment of epithelial responses to novel nanotherapeutics Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Should we adjust bronchial responsiveness for lung function, or lung function for bronchial responsiveness? Source: Eur Respir J 2004; 24: Suppl. 48, 266s Year: 2004 Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Human 3D airway models to explore in vivo inhalation Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro Source: ERS Lung Science Conference 2018 Year: 2018 The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study Source: Eur Respir J 2002; 19: 1093-1098 Year: 2002 A novel ex vivo model for the evaluation of hypoxic adaptation in non-small cell lung cancer using surgery explants Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019 Year: 2019 Automated volumetric quantification of lung emphysema: the effect of bronchiectasis and infectious lung destruction. Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 Air-liquid interface (ALI) model of human bronchial epithelia cells for the investigation of asthma exacerbations Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Physiological assessment and computational modelling of central airway obstruction caused by lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Validation of in vitro models for smoke exposure of primary human bronchial epithelial cells Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017